Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis
作者:Shaohua Hou、Xiping Yang、Yu Tong、Yuejing Yang、Quanwei Chen、Boheng Wan、Ran Wei、Yuchen Wang、Yanmin Zhang、Bo Kong、Jianhang Huang、Yadong Chen、Tao Lu、Qinghua Hu、Ding Du
DOI:10.1016/j.ejmech.2020.113114
日期:2021.2
compound 19 with a novel indole-2-carboxamide hinge scaffold. Compound 19 displays potent anti-ASK1 kinase activity and stronger inhibitory effect on ASK1 in AP1-HEK293 cells than previously described ASK1 inhibitor GS-4997. Besides improved in vitro activity, compound 19 also exhibits an appropriate in vivo PK profile. In a dextran sulfate sodium (DSS)-induced mouse model of ulcerative colitis (UC), compound
凋亡信号调节激酶1(ASK1)是丝裂原激活的蛋白激酶(MAPK)家族的成员,与许多人类疾病有关。在这里,我们描述了命中化合物7的结构优化,并进行了进一步的结构-活性关系(SAR)研究,从而开发了带有新型吲哚-2-羧酰胺铰链支架的化合物19。与先前描述的ASK1抑制剂GS-4997相比,化合物19在AP1-HEK293细胞中显示出强大的抗ASK1激酶活性和对ASK1的更强抑制作用。除了改善体外活性外,化合物19还具有适当的体内活性PK配置文件。在右旋糖酐硫酸钠(DSS)诱导的溃疡性结肠炎(UC)小鼠模型中,化合物19显示出显着的抗UC功效,并显着减轻了DSS诱导的体重减轻,结肠缩短,疾病活动指数(DAI)升高和炎症结肠组织中的细胞浸润。从机理上讲,化合物19抑制ASK1-p38 / JNK信号通路的磷酸化,并抑制炎症细胞因子的过表达。这些发现共同表明,ASK1抑制剂可以潜在地用作UC的治疗策略。